Rite Aid finalizes the acquisition of EnvisionRx
CAMP HILL, Pa. — Rite Aid has completed its acquisition of Envision Pharmaceutical Services from private investment firm TPG and other shareholders in a transaction valued at about $2 billion, including about $1.8 billion in cash, and around 27.9 million Rite Aid shares. EnvisionRx will operate as a wholly owned subsidiary of Rite Aid under